Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

Summary Aims: The IMPROVE™ observational study evaluated the safety profile and effectiveness of biphasic insulin aspart 30/70 (BIAsp 30) in patients with type 2 diabetes in routine practice in 11 countries. Methods: Patients who initiated insulin therapy with, or switched existing insulin therapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical practice (Esher) 2009-03, Vol.63 (3), p.522-531
Hauptverfasser:	Valensi, P., Benroubi, M., Borzi, V., Gumprecht, J., Kawamori, R., Shaban, J., Shah, S., Shestakova, M., Wenying, Y.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biphasic Insulins Clinical outcomes Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Drug therapy Epidemiologic Methods Female Humans Hypoglycemia - prevention & control Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Insulin Insulin - administration & dosage Insulin - adverse effects Insulin - analogs & derivatives Insulin Aspart Insulin, Isophane Male Middle Aged Patient safety Patient Satisfaction Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!